In this video, Mark Pegram, MD, director of the breast oncology program at Stanford, explains how genomic applications have been applied recently to breast cancer in terms of new molecular diagnostics and how this practice has resulted in emerging treatment opportunities. During the talk, he also discusses the potential future of diagnostics and therapeutics based on a fundamental understanding of the molecular biology of breast cancer.
Popular posts
What’s the deali-O with new weight loss drugs? Part 1
Stanford Medicine researchers weigh in on the promise and peril of increasingly popular diabetes drugs being used for weight loss.
‘Cyclic sighing’ can help breathe away anxiety
Stanford Medicine researchers showed that five minutes a day of breathing exercises can reduce overall anxiety and improve mood.